Regenxbio RGNX
NASDAQ RGNX
$7.64 +0.19 (+2.48%)
As of: Sep 30, 2026 · 3:18 PM EDT

Regenxbio (RGNX) EV to EBIT (2018 - 2022)

Updated

Regenxbio's (RGNX) EV to EBIT came in at 7.02 for Q3 2022, up 29.3% from the prior quarter.

Analysis

Regenxbio (RGNX) EV to EBIT (2018 - 2022) Analysis & Trends

For the trailing twelve months through Sep 30, 2022, EV to EBIT at Regenxbio was -4.54; for FY2021, it came in at 5.90.

  • In prior years, Regenxbio's EV to EBIT was 13.57 in FY2018.
  • Quarterly EV to EBIT has run from a low of 5.43 in Q2 2022 to a high of 33.64 in Q3 2018 over five years.
  • According to Business Quant data, EV to EBIT for the three prior quarters was 5.43 (Q2 2022), 7.79 (Q1 2022) and 5.90 (Q4 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Regenxbio 403.52 Mn -529.57 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 7.02
Jun 30, 2022 5.43
Mar 31, 2022 7.79
Dec 31, 2021 5.90
Dec 31, 2018 13.57
Sep 30, 2018 33.64
Jun 30, 2018 28.80
Mar 31, 2018 14.72
API Access

Regenxbio EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=RGNX&period=max&api_key=YOUR_API_KEY